𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C

✍ Scribed by John K. Olynyk; K.Rajender Reddy; Adrian M. di Bisceglie; Lennox J. Jeffers; Talley I. Parker; Jason L. Radick; Eugene R. Schiff; Bruce R. Bacon

Book ID
118881793
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
699 KB
Volume
108
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors of a sustained beneficial res
Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C
✍ Hari S. Conjeevaram; James E. Everhart; Jay H. Hoofnagle 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 2 views

## Predictors of a Sustained Beneficial Response to Interferon Alfa Therapy in Chronic Hepatitis C Interferon alfa was first reported to have beneficial effects in chronic hepatitis C in the mid-l980s,' effects that were subsequently verified in multiple randomized controlled trials performed in

Intrahepatic hepatitis C virus–specific
Intrahepatic hepatitis C virus–specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C
✍ David R. Nelson; Constantine G. Marousis; Tomoyoshi Ohno; Gary L. Davis; Johnson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes (CTL) have been shown to play a role in host defense and pathogenesis of chronic HCV infection. Our aim was to test the hypothesis that intrahepatic HCV-specific CTL activity may impact subsequent response to interferon alfa (IFN-␣) therapy. O

Serum hepatitis C virus RNA level as a p
Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-α therapy in Japanese patients with chronic hepatitis C
✍ Etsuro Onto; Masashi Mizokami; Tatsunori Nakano; Hisahiro Terashima; Osamu Nojir 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 1 views

## Abstract Serum hepatitis C virus (HCV) RNA level has been shown to be a good predictor of subsequent response to interferon‐α (IFN) therapy in US patients in whom genotype 1a/1b are both predominant. To determine whether serum HCV RNA level is a predictor of subsequent response to IFN in Japanes